ALS

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

Safety Study of Oral Edaravone Administered in Subjects With ALS

Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

ALS/MND Natural History Study Data Repository

Multicenter ALS Imaging Study

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

ECoG BMI for Motor and Speech Control

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Functional Outcomes and Control Using Synchron BCI - Canada

AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS

A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients

Adenosine 2A Receptor Antagonism and AIH in ALS

A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients

Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS

Chinese-Specific Speech Imagery Coding Using High-Density ECoG

Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)

Digital Speech Markers for Monitoring ALS in Spanish Speakers

Digital Tools for Assessment of Motor Functions and Falls in ALS